The Regulatory Support Center (RSC) is an expansion of the existing Center for Clinical Studies (CCS) and is a Washington University (WU) Institute of Clinical and Translational Sciences (ICTS) associated core. The RSC is designed to provide support for ICTS investigators in overcoming organizational barriers and navigating through the regulatory requirements for human research.
For more information about CCS services visit their website at ccs.wustl.edu.
Core Description
The Regulatory Core provides regulatory services to ICTS investigators that span the life of the study ranging from protocol and consent development, preparation and maintenance of FDA drug and device applications (IND/IDE), initial and ongoing submissions to the IRB, monitoring services for investigator-initiated studies, assistance and guidance with regulatory or institutional audits and study closeout processes. This group has extensive regulatory experience with these processes and collaborative working relationships with other institutional offices that oversee human research. This Regulatory Core staff will interact with the PI, FDA, sponsor (if not WU), reviewing committee(s), coordinators and other regulatory specialists, to optimally facilitate approvals.
Access
Service available to All entities, including for-profit organizations.
Priority service for No distinctions.
Services
- Pre-study consultation, IRB submissions, and other committees as required
- Prepare and negotiate industry sponsored budgets (including per patient) and payment terms with sponsors
- Perform Medicare Coverage analysis for clinical trials
- Protocol and consent development assistance for PI-initiated protocols
- Submission and maintenance of FDA IND or IDE applications
- Assistance with sponsor and regulatory audits of clinical trials
- Monitoring of investigator-initiated multi-center clinical trials
Equipment
- no equipment
Pricing
Please contact this core directly for pricing information.
AFFILIATIONS
Institute of Clinical and Translational Sciences (ICTS)
Center for Clinical Studies